Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $65.1100 (-0.58%) ($65.0200 - $66.7900) on Fri. Jun. 15, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.45% (three month average) | RSI | 78 | Latest Price | $65.1100(-0.58%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(31%) VFMO(29%) XLV(29%) BOTZ(27%) IWF(27%) | Factors Impacting SGEN price | SGEN will decline at least -1.225% in a week (0% probabilities). VIXM(-9%) UUP(-7%) VXX(-6%) DIA(-5%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.225% (StdDev 2.45%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
5 Day Moving Average | $66.92(-2.7%) | 10 Day Moving Average | $65.6(-0.75%) | 20 Day Moving Average | $61.46(5.94%) | To recent high | -5.9% | To recent low | 35.3% | Market Cap | $11.32b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |